{"ticker": {"uuid": "8958e900-32fc-431d-ac15-0c88743fde43", "symbol": "IXC", "name": "Invex Therapeutics Ltd", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Kalkine ASX Update: What Is Supporting Momentum in Invex Therapeutics (ASX: IXC)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQWGk0cnlaVVp0cGF5bnp3d3k1Q2JZVzdhLXZsVUY5bHliUnRobXN1Yl9OQ28zMklWQ2xGbGhQNU8zY1JDQlVWdGdudGRYczNySlN5a082SWwyVzlCakx5bVJ5RWFoRVYtSlZNY1VBNkFVaTVQYjZOei00WXZLUlZlbzFUX2gyT0Z5U2E4VjZKV2NJbUdfTFd3MmhnUFV1Tmprb3pWa0FVMi1WZVBROTNVYkEwQTV2UQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invex Therapeutics (ASX: IXC) Retreats as Healthcare Stocks Face Volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOeU8wcGpoT0xHQmk2TXd4eXRFcmFsWnV5VE9xUGlzbjNLTUhBUEJGUm5GY0dkZWJXNU9KS3Vjbno5dVZoRWFVQVZsM3UyT3JQVVJpNl9RZ1hPcEtkanN0ZEdpSGN6cGFzcmVjWjRGejNDSmp5OHlUeThOcVNqcFNzSEtZalpNbVJON3BrSi1Td0ZxZ2JQY2NGbll2V250cjVaTEtmQ2M4OWpBZ0dwOFlKaA?oc=5", "source_name": "Kalkine", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVEX Therapeutics Ltd (ASX: IXC) Share Price, IXC Stock News, IXC Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1QU2FNNXUwY2dUdTlmMDJUZ25YVW51cXV0ZktvVkF4WnZEVGwwYmRFeThOdVoyU3N3WkE3bmlkMDZsWkw3MjF5Q3VCSlJTcENh?oc=5", "source_name": "Kalkine", "published_at": "2023-12-29T16:11:29+00:00", "published_display": "29 Dec 2023 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Kalkine ASX Update: What Is Supporting Momentum in Invex Therapeutics (ASX: IXC)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQWGk0cnlaVVp0cGF5bnp3d3k1Q2JZVzdhLXZsVUY5bHliUnRobXN1Yl9OQ28zMklWQ2xGbGhQNU8zY1JDQlVWdGdudGRYczNySlN5a082SWwyVzlCakx5bVJ5RWFoRVYtSlZNY1VBNkFVaTVQYjZOei00WXZLUlZlbzFUX2gyT0Z5U2E4VjZKV2NJbUdfTFd3MmhnUFV1Tmprb3pWa0FVMi1WZVBROTNVYkEwQTV2UQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invex Therapeutics (ASX: IXC) Retreats as Healthcare Stocks Face Volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOeU8wcGpoT0xHQmk2TXd4eXRFcmFsWnV5VE9xUGlzbjNLTUhBUEJGUm5GY0dkZWJXNU9KS3Vjbno5dVZoRWFVQVZsM3UyT3JQVVJpNl9RZ1hPcEtkanN0ZEdpSGN6cGFzcmVjWjRGejNDSmp5OHlUeThOcVNqcFNzSEtZalpNbVJON3BrSi1Td0ZxZ2JQY2NGbll2V250cjVaTEtmQ2M4OWpBZ0dwOFlKaA?oc=5", "source_name": "Kalkine", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVEX Therapeutics Ltd (ASX: IXC) Share Price, IXC Stock News, IXC Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE1QU2FNNXUwY2dUdTlmMDJUZ25YVW51cXV0ZktvVkF4WnZEVGwwYmRFeThOdVoyU3N3WkE3bmlkMDZsWkw3MjF5Q3VCSlJTcENh?oc=5", "source_name": "Kalkine", "published_at": "2023-12-29T16:11:29+00:00", "published_display": "29 Dec 2023 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 77, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.1, "latest_week": "2026-07-10", "one_week_move": 10.5, "four_week_move": -12.5, "twelve_week_move": 12.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.285398, "market_dynamics_buy_signal": false, "relative_strength": -6.96054, "fair_value_gap": 21.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.6561, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+10.5% over one week, -12.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+10.5% over one week, -12.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Kalkine ASX Update: What Is Supporting Momentum in Invex Therapeutics (ASX: IXC)?"}], "updated_at": "2026-07-17T11:24:12.345060+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}